Claude will manage robotic laboratory systems with minimal human oversight to study traditionally undruggable and rare diseases. The AI developer established a physical wet lab in the San Francisco Bay Area to move its life sciences research beyond digital simulations. Life sciences head Eric Kauderer-Abrams stated the facility enables real-world biological experiments to accelerate drug development.

Anthropic focuses exclusively on preclinical research to avoid direct competition with pharmaceutical firms and will not conduct clinical trials. This expansion into physical biology occurs as some internal researchers warn that advanced AI capabilities could potentially enable the creation of biological weapons or cause catastrophic harm.